Dec 2 (Reuters) - Shares of Medicis Pharmaceutical Corp rose as much as 27 percent on Tuesday, a day after Impax Laboratories confirmed that Medicis' patents relating to acne drug Solodyn were valid and enforceable. On Monday, the companies also ...
Read more...
Medicis Pharmaceutical Corp. said late Monday it cut a deal with potential competitor Impax Laboratories Inc. that ends a patent dispute over a generic version of the acne drug Solodyn and has the companies developing a more advanced version of the ...
Read more...
Q: As a teenager, I was blessed with relatively few blemishes. Now in my mid-20s, I have developed large, deep pimples that heal slowly and have eroded my self-esteem. I had tried everything, from expensive department-store skin-care regimens to acid ...
Read more...
The companies announced a settlement of the patent dispute over a generic version of the acne drug Solodyn. NEW YORK (CNNMoney.com) -- Shares of Medicis Pharmaceutical Corp. rose more than 25% in midday trading Tuesday, following the settlement of a ...
Read more...
NEW YORK (Associated Press) - Shares of Medicis Pharmaceutical Corp. jumped Tuesday after the company settled a patent dispute over its acne drug Solodyn, removing the immediate threat of generic competition to a key revenue driver. The stock jumped ...
Read more...
Acne sufferers can fight cold weather dry skin which exacerbates acne breakouts and have clear skin for the holidays with the Exposed Skin Care Solution featuring a combination of both scientific and natural additives to treat acne quickly and ...
Read more...
People who take the acne drug Accutane (isoretinoin), may be at risk for high cholesterol. Researchers from the University of California, San Franscisco, looked at the blood tests of almost 13,772 patients who took the drug between 1995 and 2002 ...
Read more...